In another study, using a combination of WGS and WES data, mutations in enhancer regions near the PAX5 gene, a transcription factor implicated in B cell differentiation, was identified in chronic lymphocytic leukaemia (CLL) patients and diffuse large B cell, follicular and mantle-cell lymphomas [16]. Here, PAX5 is linked to B-cell chronic lymphocytic leukemia.